FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA takes first step in possible reversal of ban on some peptides The Washington Post The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them RFK Jr. & claimed regenerative peptides like BPC 157 The Niche